Table 2.
Patient | Age | Gender | Location | Tumor lateralization | cT | pT | cN | pN | LN side | LN details |
---|---|---|---|---|---|---|---|---|---|---|
Pt1 | 64 | F | Supraglottis | Lateralized left | 2 | 1 | 0 | 1 | left | Level 1 (1 LN, micrometastasis < 1 mm) |
Pt2 | 77 | M | Supraglottis | Not lateralized | 3 | 3 | 0 | 2b | left | Level 1 (2 LN, metastases both < 10 mm) |
Pt3 | 70 | M | Supraglottis | Not lateralized | 4a | 4a | 0 | 2c | bilateral | Level IIa right (1 LN, cystic metastasis), Level IIa left (1 LN, 8 mm) |
Pt4 | 64 | F | Supraglottis | Not lateralized | 2 | 3 | 0 | 2c | bilateral | Level II left (1 LN 16 mm) Level III left (1 LN) 14 mm, Level III right (1 LN metastasis) |
Pt5 | 68 | M | Supraglottis | Not lateralized | 4 | 4a | 0 | 3b | left | Level II (2 metastases), Level III (2 metastases, 1 ENE +) |
F female, M male, LN lymph node, ENE extra nodal extension